<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Musculoskelet Disord</journal-id><journal-title>BMC Musculoskeletal Disorders</journal-title><issn pub-type="epub">1471-2474</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">2253535</article-id><article-id pub-id-type="publisher-id">1471-2474-9-2</article-id><article-id pub-id-type="doi">10.1186/1471-2474-9-2</article-id><article-categories><subj-group subj-group-type="heading"><subject>Study Protocol</subject></subj-group></article-categories><title-group><article-title>Effectiveness of a psycho-educational program for improving quality of life of fibromyalgia patients</article-title></title-group><contrib-group><contrib id="A1" corresp="yes" contrib-type="author"><name><surname>Fernández</surname><given-names>Rita</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>32432rfv@comb.es</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Peñarubia</surname><given-names>Maria T</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>32829mpm@comb.es</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Luciano</surname><given-names>Juan V</given-names></name><xref ref-type="aff" rid="I2">2</xref><xref ref-type="aff" rid="I3">3</xref><email>jvluciano@sjd-ssm.com</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Blanco</surname><given-names>Maria E</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>irises_1999@yahoo.com</email></contrib><contrib id="A5" contrib-type="author"><name><surname>Jiménez</surname><given-names>Mónica</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>mjimen@hotmail.com</email></contrib><contrib id="A6" contrib-type="author"><name><surname>Montesano</surname><given-names>Adrián</given-names></name><xref ref-type="aff" rid="I4">4</xref><email>adrianmontesano@gmail.com</email></contrib><contrib id="A7" contrib-type="author"><name><surname>Verduras</surname><given-names>Camino</given-names></name><xref ref-type="aff" rid="I5">5</xref><email>cverduras.cp.ics@gencat.net</email></contrib><contrib id="A8" contrib-type="author"><name><surname>Ruiz</surname><given-names>José M</given-names></name><xref ref-type="aff" rid="I6">6</xref><email>jmruiz.hv@ics.scs.es</email></contrib><contrib id="A9" contrib-type="author"><name><surname>Serrano-Blanco</surname><given-names>Antoni</given-names></name><xref ref-type="aff" rid="I2">2</xref><xref ref-type="aff" rid="I3">3</xref><email>aserrano@sjd-ssm.com</email></contrib><contrib id="A10" contrib-type="author"><collab>FibroQoL Study Group</collab><email>32432rfv@comb.es</email></contrib></contrib-group><aff id="I1"><label>1</label>ABS Bartomeu Fabrés Anglada, DAP Baix Llobregat Litoral, Unitat Docent Costa de Ponent, Institut Català de la Salut Gavà, Spain</aff><aff id="I2"><label>2</label>Red de Investigación en Actividades Preventivas y Promoción de la Salud en Atención Primaria RedIAPP, Spain</aff><aff id="I3"><label>3</label>Sant Joan de Déu-Serveis de Salut Mental, Fundació Sant Joan de Déu, Sant Boi de Llobregat, Spain</aff><aff id="I4"><label>4</label>Fundació Jordi Gol i Gorina, Barcelona, Spain</aff><aff id="I5"><label>5</label>ABS Viladecans-2, Institut Català de la Salut, Viladecans, Spain</aff><aff id="I6"><label>6</label>Servei de Reumatología, Hospital de Viladecans, Institut Català de la Salut, Viladecans, Spain</aff><pub-date pub-type="collection"><year>2008</year></pub-date><pub-date pub-type="epub"><day>10</day><month>1</month><year>2008</year></pub-date><volume>9</volume><fpage>2</fpage><lpage>2</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2474/9/2"></ext-link><history><date date-type="received"><day>13</day><month>11</month><year>2007</year></date><date date-type="accepted"><day>10</day><month>1</month><year>2008</year></date></history><permissions><copyright-statement>Copyright © 2008 Fernández et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2008</copyright-year><copyright-holder>Fernández et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"></ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license></permissions><abstract><sec><title><offsets xml_i="4798" xml_f="4808" txt_i="11" txt_f="21">Background</offsets></title><p><offsets xml_i="4819" xml_f="5291" txt_i="22" txt_f="494">Most fibromyalgia patients are seen in primary care (PC). However, the effectiveness of the treatments prescribed by general practitioners is usually minimal. The main objective of the present research is to assess the efficacy of structured psycho-educational intervention, combined with relaxation, developed to improve the quality of life of patients suffering fibromyalgia (FM). The second objective is to assess the cost-effectiveness of this multimodal intervention.</offsets></p></sec><sec><title><offsets xml_i="5313" xml_f="5326" txt_i="496" txt_f="509">Method/Design</offsets></title><p><italic><offsets xml_i="5345" xml_f="5351" txt_i="510" txt_f="516">Design</offsets></italic><offsets xml_i="5360" xml_f="5625" txt_i="516" txt_f="781">. Randomized controlled trial with a 12-month follow-up involving two groups, one of which is the intervention group that includes patients receiving a psychoeducational program and the other the control group consisting of patients treated for FM in the usual way.</offsets></p><p><italic><offsets xml_i="5640" xml_f="5647" txt_i="782" txt_f="789">Setting</offsets></italic><offsets xml_i="5656" xml_f="5718" txt_i="789" txt_f="851">. Three urban PC centers in the province of Barcelona (Spain).</offsets></p><p><italic><offsets xml_i="5733" xml_f="5739" txt_i="852" txt_f="858">Sample</offsets></italic><offsets xml_i="5748" xml_f="6126" txt_i="858" txt_f="1236">. The total sample comprises 218 patients (over 18 years of age) suffering FM, selected from a database (Rheumatology service-Viladecans Hospital) of patients with this illness. Only those patients introduced in the database between the years 2005 and 2007 were included in the selection. Selected patients will be asked for written informed consent to participate in the study.</offsets></p><p><italic><offsets xml_i="6141" xml_f="6153" txt_i="1237" txt_f="1249">Intervention</offsets></italic><offsets xml_i="6162" xml_f="6478" txt_i="1249" txt_f="1565">. Multi-component program including information about the illness, counselling about physical exercise and training in autogenic relaxation. The intervention consists of nine 2-hour sessions delivered during a two-month period. The pharmacological treatment prescribed by the physician was maintained in both groups.</offsets></p><p><italic><offsets xml_i="6493" xml_f="6507" txt_i="1566" txt_f="1580">Main variables</offsets></italic><offsets xml_i="6516" xml_f="6616" txt_i="1580" txt_f="1680">. Sociodemographic characteristics, quality of life, use and cost of healthcare and social services.</offsets></p><p><italic><offsets xml_i="6631" xml_f="6639" txt_i="1681" txt_f="1689">Measures</offsets></italic><offsets xml_i="6648" xml_f="6936" txt_i="1689" txt_f="1977">. Quality of life is to be measured with the FIQ and the EuroQol-5D, and the use of healthcare services with an adapted version of the Client Service Receipt Inventory (CSRI). These variables will be measured before the beginning of the program (baseline) and 1, 2, 6 and 12 months later.</offsets></p></sec><sec><title><offsets xml_i="6958" xml_f="6968" txt_i="1979" txt_f="1989">Discussion</offsets></title><p><offsets xml_i="6979" xml_f="7270" txt_i="1990" txt_f="2281">This research project is an attempt to demonstrate that a psycho-educational program implemented in the context of PC can produce a significant increase in the quality of life for patients with FM, as well as a decrease in the use of healthcare and social services, compared with usual care.</offsets></p></sec><sec><title><offsets xml_i="7292" xml_f="7310" txt_i="2283" txt_f="2301">Trial registration</offsets></title><p><offsets xml_i="7321" xml_f="7332" txt_i="2302" txt_f="2313">NCT00550966</offsets></p></sec></abstract></article-meta></front><body><sec><title><offsets xml_i="7394" xml_f="7404" txt_i="2322" txt_f="2332">Background</offsets></title><p><offsets xml_i="7415" xml_f="7597" txt_i="2333" txt_f="2515">Fibromyalgia (FM) is a chronic illness of unknown origin that provokes intense widespread pain and fatigue and affects people in the biological, psychological and social dimensions [</offsets><xref ref-type="bibr" rid="B1"><offsets xml_i="7628" xml_f="7629" txt_i="2515" txt_f="2516">1</offsets></xref><offsets xml_i="7636" xml_f="7637" txt_i="2516" txt_f="2517">-</offsets><xref ref-type="bibr" rid="B3"><offsets xml_i="7668" xml_f="7669" txt_i="2517" txt_f="2518">3</offsets></xref><offsets xml_i="7676" xml_f="7918" txt_i="2518" txt_f="2760">]. The diagnosis of FM is mainly clinical and the practitioner takes into account patient history, physical examination and laboratory evaluations. The American College of Rheumatology (ACR) established two major diagnostic criteria in 1990 [</offsets><xref ref-type="bibr" rid="B4"><offsets xml_i="7949" xml_f="7950" txt_i="2760" txt_f="2761">4</offsets></xref><offsets xml_i="7957" xml_f="8320" txt_i="2761" txt_f="3124">]: first, a history of widespread pain for at least three months, and second, patient reporting of tenderness in at least 11 of 18 defined tender points when digitally palpated with about 4 Kg per unit area of force. The absence of reliable diagnostic tools has generated the need for employing subjective scales to assess the pain and fatigue of these patients [</offsets><xref ref-type="bibr" rid="B2"><offsets xml_i="8351" xml_f="8352" txt_i="3124" txt_f="3125">2</offsets></xref><offsets xml_i="8359" xml_f="8361" txt_i="3125" txt_f="3127">].</offsets></p><p><offsets xml_i="8368" xml_f="8484" txt_i="3128" txt_f="3244">The prevalence of FM in the general population is about 2–4%, and it is nine times more frequent in women than men [</offsets><xref ref-type="bibr" rid="B1"><offsets xml_i="8515" xml_f="8516" txt_i="3244" txt_f="3245">1</offsets></xref><offsets xml_i="8523" xml_f="8524" txt_i="3245" txt_f="3246">,</offsets><xref ref-type="bibr" rid="B3"><offsets xml_i="8555" xml_f="8556" txt_i="3246" txt_f="3247">3</offsets></xref><offsets xml_i="8563" xml_f="8616" txt_i="3247" txt_f="3300">]. In PC consultations the prevalence is about 5–7% [</offsets><xref ref-type="bibr" rid="B5"><offsets xml_i="8647" xml_f="8648" txt_i="3300" txt_f="3301">5</offsets></xref><offsets xml_i="8655" xml_f="8789" txt_i="3301" txt_f="3435">]. Given its high prevalence and morbidity, patients suffering FM present an elevated frequency of use index for healthcare resources.</offsets></p><p><offsets xml_i="8796" xml_f="8874" txt_i="3436" txt_f="3514">Although the aetiology of FM is still unknown, it is probably multifactorial [</offsets><xref ref-type="bibr" rid="B6"><offsets xml_i="8905" xml_f="8906" txt_i="3514" txt_f="3515">6</offsets></xref><offsets xml_i="8913" xml_f="8914" txt_i="3515" txt_f="3516">-</offsets><xref ref-type="bibr" rid="B9"><offsets xml_i="8945" xml_f="8946" txt_i="3516" txt_f="3517">9</offsets></xref><offsets xml_i="8953" xml_f="9083" txt_i="3517" txt_f="3647">], which is why multidisciplinary and biopsychosocial approaches usually obtain better outcomes than symptomatic treatment alone [</offsets><xref ref-type="bibr" rid="B10"><offsets xml_i="9115" xml_f="9117" txt_i="3647" txt_f="3649">10</offsets></xref><offsets xml_i="9124" xml_f="9125" txt_i="3649" txt_f="3650">-</offsets><xref ref-type="bibr" rid="B13"><offsets xml_i="9157" xml_f="9159" txt_i="3650" txt_f="3652">13</offsets></xref><offsets xml_i="9166" xml_f="9589" txt_i="3652" txt_f="4075">]. The main goal of most treatments is to reduce muscular dysfunction and functional impotence caused by pain. Among pharmacological treatments, only a minority has demonstrated significant efficacy. As far as we know, there is evidence of the efficacy of amitriptyline and cyclobenzaprine, whereas studies focused on the efficacy of tramadol and selective serotonin re-uptake inhibitors have yielded only modest evidence [</offsets><xref ref-type="bibr" rid="B14"><offsets xml_i="9621" xml_f="9623" txt_i="4075" txt_f="4077">14</offsets></xref><offsets xml_i="9630" xml_f="9632" txt_i="4077" txt_f="4079">].</offsets></p><p><offsets xml_i="9639" xml_f="9817" txt_i="4080" txt_f="4258">Non-extenuating physical exercise and some relaxation therapies can also increase pain tolerance, producing a global improvement in the quality of life of fibromyalgia patients [</offsets><xref ref-type="bibr" rid="B15"><offsets xml_i="9849" xml_f="9851" txt_i="4258" txt_f="4260">15</offsets></xref><offsets xml_i="9858" xml_f="9859" txt_i="4260" txt_f="4261">,</offsets><xref ref-type="bibr" rid="B16"><offsets xml_i="9891" xml_f="9893" txt_i="4261" txt_f="4263">16</offsets></xref><offsets xml_i="9900" xml_f="9917" txt_i="4263" txt_f="4280">]. Gowans et al [</offsets><xref ref-type="bibr" rid="B16"><offsets xml_i="9949" xml_f="9951" txt_i="4280" txt_f="4282">16</offsets></xref><offsets xml_i="9958" xml_f="10215" txt_i="4282" txt_f="4539">] assessed physical functioning and mood state 6 and 12 months after the beginning of a supervised aerobic physical exercise program. These authors observed an improvement in participants' health when the program finished and 6 months later. Taggart et al [</offsets><xref ref-type="bibr" rid="B17"><offsets xml_i="10247" xml_f="10249" txt_i="4539" txt_f="4541">17</offsets></xref><offsets xml_i="10256" xml_f="10389" txt_i="4541" txt_f="4674">] reported a satisfactory and significant increase in the quality of life of fibromyalgic patients after a 6-week relaxation program.</offsets></p><p><offsets xml_i="10396" xml_f="10500" txt_i="4675" txt_f="4779">Another key component in current treatment of FM is the education of patients concerning their illness [</offsets><xref ref-type="bibr" rid="B18"><offsets xml_i="10532" xml_f="10534" txt_i="4779" txt_f="4781">18</offsets></xref><offsets xml_i="10541" xml_f="10542" txt_i="4781" txt_f="4782">-</offsets><xref ref-type="bibr" rid="B20"><offsets xml_i="10574" xml_f="10576" txt_i="4782" txt_f="4784">20</offsets></xref><offsets xml_i="10583" xml_f="10933" txt_i="4784" txt_f="5134">]. The main objective of educational programs is to increase skills in coping and healthy behaviour on the part of patients suffering FM. Scientific evidence has demonstrated that intensive education programs (between 6 and 17 sessions) improve pain symptoms, fatigue, insomnia and quality of life. These improvements continue 3 and 12 months later [</offsets><xref ref-type="bibr" rid="B14"><offsets xml_i="10965" xml_f="10967" txt_i="5134" txt_f="5136">14</offsets></xref><offsets xml_i="10974" xml_f="11299" txt_i="5136" txt_f="5461">]. Furthermore, educational programs increase patient autonomy, reducing at the same time the consumption of medicines and use of healthcare services. The total cost of the continuous use of healthcare services by FM patients has not been estimated in Spain, but data from the USA reveal an annual cost of $2,274 per patient.</offsets></p><p><offsets xml_i="11306" xml_f="11660" txt_i="5462" txt_f="5816">To date, it has not been demonstrated in Spain whether a multimodal program, combining autogenic relaxation and active healthcare education, produces a significant improvement in the quality of life of patients with FM. In addition, we do not know whether a multimodal program is more cost-effective than the treatment usually provided to these patients.</offsets></p><p><offsets xml_i="11667" xml_f="12364" txt_i="5817" txt_f="6514">With this background, then, the main objective of the present research project will be to determine whether a multi-component psycho-educational program for treating FM leads to better quality of life (measured with the FIQ and the EuroQol-5D) at 1, 2, 6 and 12 months, than the usual care provided in Catalan Primary Health Care. The specific aims are to assess the degree of pain perceived by fibromyalgia patients attending the multimodal program, as well as the total direct costs (medication consumption and visits to public or private healthcare professionals) and indirect (work days lost), and cost-effectiveness associated with this psychoeducational intervention, compared to usual care.</offsets></p></sec><sec><title><offsets xml_i="12386" xml_f="12400" txt_i="6516" txt_f="6530">Methods/Design</offsets></title><sec><title><offsets xml_i="12420" xml_f="12426" txt_i="6531" txt_f="6537">Design</offsets></title><p><offsets xml_i="12437" xml_f="12523" txt_i="6538" txt_f="6624">Controlled trial with a random allocation of participants in two alternative branches:</offsets></p><p><offsets xml_i="12530" xml_f="12645" txt_i="6625" txt_f="6740">1. Implementation of a multimodal psycho-educational program to improve quality of life in FM (intervention group).</offsets></p><p><offsets xml_i="12652" xml_f="12688" txt_i="6741" txt_f="6777">2. Usual care of FM (control group).</offsets></p><p><offsets xml_i="12695" xml_f="12876" txt_i="6778" txt_f="6959">Evaluation of treatment outcomes will be carried out at the patient level, with individual evaluation at baseline and 1, 2, 6, and 12 months after the beginning of the intervention.</offsets></p></sec><sec><title><offsets xml_i="12898" xml_f="12922" txt_i="6961" txt_f="6985">Setting and study sample</offsets></title><p><offsets xml_i="12933" xml_f="13353" txt_i="6986" txt_f="7406">Three primary health care centres (Viladecans-2, Gavà-1 and Gavà-2) in the province of Barcelona (Catalonia, Spain) voluntarily participated for the study. The sample pool (n = 530) comprises only those patients included in a FM database of the Viladecans Hospital for the years 2005 and 2006. In the event of a lack of participants, the plan is to recruit patients with FM included in the database during the year 2007.</offsets></p><p><offsets xml_i="13360" xml_f="13885" txt_i="7407" txt_f="7932">Patients considered for inclusion will be those aged 18–75 years-old, contactable by telephone, who meet the diagnostic criteria of FM established by the ACR. The following patients will be excluded: those with a diagnosis not based on the ACR criteria, those with cognitive impairment or suffering from physical, mental/psychiatric limitations or a severe concurrent rheumatologic illness that impedes participation in the study evaluations, those who are not expected to live at least 12 months and those without schooling.</offsets></p><p><offsets xml_i="13892" xml_f="14196" txt_i="7933" txt_f="8237">To calculate the sample size it was taken into account that we need to obtain a difference of at least 5 points in the FIQ between those that respond and those who are resistant to the intervention. The criterion of 5 points is based on two previous studies conducted with Spanish fibromyalgia patients [</offsets><xref ref-type="bibr" rid="B21"><offsets xml_i="14228" xml_f="14230" txt_i="8237" txt_f="8239">21</offsets></xref><offsets xml_i="14237" xml_f="14238" txt_i="8239" txt_f="8240">,</offsets><xref ref-type="bibr" rid="B22"><offsets xml_i="14270" xml_f="14272" txt_i="8240" txt_f="8242">22</offsets></xref><offsets xml_i="14279" xml_f="14492" txt_i="8242" txt_f="8452">]. A total of 109 patients per condition is needed to conduct the study, assuming an alpha risk of 0.05 and a beta risk of &lt; 0.20 in a bilateral contrast, a standard error of 12.1 reported in a previous study [</offsets><xref ref-type="bibr" rid="B21"><offsets xml_i="14524" xml_f="14526" txt_i="8452" txt_f="8454">21</offsets></xref><offsets xml_i="14533" xml_f="14559" txt_i="8454" txt_f="8480">], and a 15% dropout rate.</offsets></p></sec><sec><title><offsets xml_i="14581" xml_f="14616" txt_i="8482" txt_f="8517">Data collection and ethical aspects</offsets></title><p><offsets xml_i="14627" xml_f="15316" txt_i="8518" txt_f="9207">First, patients that meet the inclusion criteria will be phoned by a research assistant who is a psychologist. Second, the research assistant will make an appointment with those patients that agree to participate in the study. Third, written consent will be obtained before the beginning of the study. Participants will be provided with a general overview of the aims and activities of the study. They will be also informed that they may choose to drop out at any time with the guarantee that they will continue to receive the treatment considered most appropriate by their physician. Patients in the control group will receive the treatment considered most appropriate by their physician.</offsets></p><p><offsets xml_i="15323" xml_f="15755" txt_i="9208" txt_f="9640">Results will be monitored and most of data collected by means of standard questionnaires conducted in face-to-face interview by the research assistant, who has been trained in the administration of the instruments. The research assistant does not know which study group the patients being interviewed belong to ("blind"). Follow-up assessments shall take place at 1, 2, 6 and 12 months after the inclusion of the patient (see Table </offsets><xref ref-type="table" rid="T1"><offsets xml_i="15787" xml_f="15788" txt_i="9640" txt_f="9641">1</offsets></xref><offsets xml_i="15795" xml_f="15797" txt_i="9641" txt_f="9643">).</offsets></p><table-wrap position="float" id="T1"><label><offsets xml_i="15845" xml_f="15852" txt_i="9644" txt_f="9651">Table 1</offsets></label><caption><p><offsets xml_i="15872" xml_f="15894" txt_i="9651" txt_f="9673">Follow-up assessments.</offsets></p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="left"><bold><offsets xml_i="15979" xml_f="15986" txt_i="9674" txt_f="9681">Month 1</offsets></bold></td></tr><tr><td align="left"><offsets xml_i="16024" xml_f="16029" txt_i="9682" txt_f="9687">• FIQ</offsets></td></tr><tr><td align="left"><offsets xml_i="16060" xml_f="16125" txt_i="9688" txt_f="9753">• Sociodemographic variables: 1 question (current work situation)</offsets></td></tr><tr><td align="left"><offsets xml_i="16156" xml_f="16238" txt_i="9754" txt_f="9836">• Pharmacological and non-pharmacological treatment received during the last month</offsets></td></tr><tr><td align="left"><bold><offsets xml_i="16275" xml_f="16282" txt_i="9837" txt_f="9844">Month 2</offsets></bold></td></tr><tr><td align="left"><offsets xml_i="16320" xml_f="16325" txt_i="9845" txt_f="9850">• FIQ</offsets></td></tr><tr><td align="left"><offsets xml_i="16356" xml_f="16421" txt_i="9851" txt_f="9916">• Sociodemographic variables: 1 question (current work situation)</offsets></td></tr><tr><td align="left"><offsets xml_i="16452" xml_f="16534" txt_i="9917" txt_f="9999">• Pharmacological and non-pharmacological treatment received during the last month</offsets></td></tr><tr><td align="left"><bold><offsets xml_i="16571" xml_f="16578" txt_i="10000" txt_f="10007">Month 6</offsets></bold></td></tr><tr><td align="left"><offsets xml_i="16616" xml_f="16621" txt_i="10008" txt_f="10013">• FIQ</offsets></td></tr><tr><td align="left"><offsets xml_i="16652" xml_f="16717" txt_i="10014" txt_f="10079">• Sociodemographic variables: 1 question (current work situation)</offsets></td></tr><tr><td align="left"><offsets xml_i="16748" xml_f="16836" txt_i="10080" txt_f="10168">• Pharmacological and non-pharmacological treatment received during the last four months</offsets></td></tr><tr><td align="left"><offsets xml_i="16867" xml_f="16969" txt_i="10169" txt_f="10271">• CSRI-adapted version: use of healthcare and social services during the first six months (0–6 months)</offsets></td></tr><tr><td align="left"><offsets xml_i="17000" xml_f="17012" txt_i="10272" txt_f="10284">• EuroQoL-5D</offsets></td></tr><tr><td align="left"><bold><offsets xml_i="17049" xml_f="17057" txt_i="10285" txt_f="10293">Month 12</offsets></bold></td></tr><tr><td align="left"><offsets xml_i="17095" xml_f="17100" txt_i="10294" txt_f="10299">• FIQ</offsets></td></tr><tr><td align="left"><offsets xml_i="17131" xml_f="17196" txt_i="10300" txt_f="10365">• Sociodemographic variables: 1 question (current work situation)</offsets></td></tr><tr><td align="left"><offsets xml_i="17227" xml_f="17314" txt_i="10366" txt_f="10453">• Pharmacological and non-pharmacological treatment received during the last six months</offsets></td></tr><tr><td align="left"><offsets xml_i="17345" xml_f="17448" txt_i="10454" txt_f="10557">• CSRI-adapted version: use of healthcare and social services during the first six months (6–12 months)</offsets></td></tr><tr><td align="left"><offsets xml_i="17479" xml_f="17491" txt_i="10558" txt_f="10570">• EuroQoL-5D</offsets></td></tr></tbody></table></table-wrap></sec><sec><title><offsets xml_i="17548" xml_f="17588" txt_i="10572" txt_f="10612">Variables and instruments of measurement</offsets></title><p><offsets xml_i="17599" xml_f="17753" txt_i="10613" txt_f="10767">The study protocol was approved by the research ethics committee of the Foundation Jordi Gol i Gorina (Barcelona) and consists of the following materials:</offsets></p><p><offsets xml_i="17760" xml_f="17763" txt_i="10768" txt_f="10771">1. </offsets><italic><offsets xml_i="17771" xml_f="17803" txt_i="10771" txt_f="10803">Sociodemographic characteristics</offsets></italic><offsets xml_i="17812" xml_f="17888" txt_i="10803" txt_f="10879">: Gender, birth date, address, marital status, education level, work status.</offsets></p><p><offsets xml_i="17895" xml_f="17898" txt_i="10880" txt_f="10883">2. </offsets><italic><offsets xml_i="17906" xml_f="17928" txt_i="10883" txt_f="10905">History of the illness</offsets></italic><offsets xml_i="17937" xml_f="18286" txt_i="10905" txt_f="11254">: age of onset, date of the first diagnosis, pharmacological treatments (oral antidepressants, benzodiazepines-hypnotics, muscular relaxants and non-steroid analgesic and anti-inflammatory medications) and non-pharmacological treatments (physical exercise, relaxation techniques, cognitive-behavioural therapy) received during the previous 6 months.</offsets></p><p><offsets xml_i="18293" xml_f="18296" txt_i="11255" txt_f="11258">3. </offsets><italic><offsets xml_i="18304" xml_f="18346" txt_i="11258" txt_f="11300">Questionnaire on chronic medical condition</offsets></italic><offsets xml_i="18355" xml_f="18356" txt_i="11300" txt_f="11301">.</offsets></p><p><offsets xml_i="18363" xml_f="18366" txt_i="11302" txt_f="11305">4. </offsets><italic><offsets xml_i="18374" xml_f="18430" txt_i="11305" txt_f="11361">Fibromyalgia Impact Questionnaire (FIQ-Spanish version) </offsets></italic><offsets xml_i="18439" xml_f="18440" txt_i="11361" txt_f="11362">[</offsets><xref ref-type="bibr" rid="B23"><offsets xml_i="18472" xml_f="18474" txt_i="11362" txt_f="11364">23</offsets></xref><offsets xml_i="18481" xml_f="18862" txt_i="11364" txt_f="11745">]: Instrument that measures physical function, work, and well-being, and contains visual analogue scales (VAS) for pain, sleep, fatigue, stiffness, anxiety and depression. A total score may be obtained after normalization of some items (between 0–10) and adding them to the VAS. Total scores range between 0–80 (without job items), with a higher score indicating a negative impact.</offsets></p><p><offsets xml_i="18869" xml_f="18872" txt_i="11746" txt_f="11749">5. </offsets><italic><offsets xml_i="18880" xml_f="18931" txt_i="11749" txt_f="11800">EuroQoL-5D questionnaire (EQ-5D – Spanish version) </offsets></italic><offsets xml_i="18940" xml_f="18941" txt_i="11800" txt_f="11801">[</offsets><xref ref-type="bibr" rid="B22"><offsets xml_i="18973" xml_f="18975" txt_i="11801" txt_f="11803">22</offsets></xref><offsets xml_i="18982" xml_f="19514" txt_i="11803" txt_f="12335">]: Generic instrument of health-related quality of life. It has two parts: Part 1 records self-reported problems in each of five domains: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each domain is divided into three levels of severity corresponding to no problems, some problems, and extreme problems. Part 2 records the subject's self-assessed health on a Visual Analogue Scale (VAS); it is a vertical 10 cm line on which the best and worst imaginable health states score 100 and 0, respectively.</offsets></p><p><offsets xml_i="19521" xml_f="19524" txt_i="12336" txt_f="12339">6. </offsets><italic><offsets xml_i="19532" xml_f="19600" txt_i="12339" txt_f="12407">Client Service Receipt Inventory – adapted (CSRI – Spanish version) </offsets></italic><offsets xml_i="19609" xml_f="19610" txt_i="12407" txt_f="12408">[</offsets><xref ref-type="bibr" rid="B24"><offsets xml_i="19642" xml_f="19644" txt_i="12408" txt_f="12410">24</offsets></xref><offsets xml_i="19651" xml_f="20013" txt_i="12410" txt_f="12772">]: questionnaire for collecting information about use of healthcare and social care services, other economic impacts (such as time off work due to illness) and socio-demographic information. The variant used in this study was designed to collect retrospective data on service utilisation during the first and last six months after the beginning of the treatment.</offsets></p></sec><sec><title><offsets xml_i="20035" xml_f="20055" txt_i="12774" txt_f="12794">Intervention program</offsets></title><p><offsets xml_i="20066" xml_f="20432" txt_i="12795" txt_f="13161">Participants from the intervention group will undergo a multi-component psycho-educational program that deals with FM based on available scientific evidence. It includes measures and instruments that can be employed within the Catalan Primary Health Care, whereas the participants from the control group will receive only the treatment prescribed by their physician.</offsets></p><p><offsets xml_i="20439" xml_f="20739" txt_i="13162" txt_f="13462">The intervention program consists of nine 2-hour sessions delivered during a two month period. Participants will be allocated in groups with a maximum of 18 subjects per group. All sessions will take place at the PC centres Gava-2 or Viladecans-2. The contents of each session are displayed in Table </offsets><xref ref-type="table" rid="T2"><offsets xml_i="20771" xml_f="20772" txt_i="13462" txt_f="13463">2</offsets></xref><offsets xml_i="20779" xml_f="20780" txt_i="13463" txt_f="13464">.</offsets></p><table-wrap position="float" id="T2"><label><offsets xml_i="20828" xml_f="20835" txt_i="13465" txt_f="13472">Table 2</offsets></label><caption><p><offsets xml_i="20855" xml_f="20891" txt_i="13472" txt_f="13508">Summary of the intervention program.</offsets></p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="left"><bold><offsets xml_i="20976" xml_f="20987" txt_i="13509" txt_f="13520">Session 1: </offsets></bold><offsets xml_i="20994" xml_f="21166" txt_i="13520" txt_f="13692">General information. Expectations of the patients. History of the illness. Principal and secondary symptoms in FM. Physiological mechanisms involved in the genesis of pain.</offsets></td></tr><tr><td align="left"><bold><offsets xml_i="21203" xml_f="21214" txt_i="13693" txt_f="13704">Session 2: </offsets></bold><offsets xml_i="21221" xml_f="21242" txt_i="13704" txt_f="13725">Relaxation training-I</offsets></td></tr><tr><td align="left"><bold><offsets xml_i="21279" xml_f="21290" txt_i="13726" txt_f="13737">Session 3: </offsets></bold><offsets xml_i="21297" xml_f="21455" txt_i="13737" txt_f="13895">Diagnosis. Pharmacological and non-pharmacological treatments. Prognosis. Current model of health care in Catalonia. Units specialized in the treatment of FM.</offsets></td></tr><tr><td align="left"><bold><offsets xml_i="21492" xml_f="21503" txt_i="13896" txt_f="13907">Session 4: </offsets></bold><offsets xml_i="21510" xml_f="21532" txt_i="13907" txt_f="13929">Relaxation training-II</offsets></td></tr><tr><td align="left"><bold><offsets xml_i="21569" xml_f="21580" txt_i="13930" txt_f="13941">Session 5: </offsets></bold><offsets xml_i="21587" xml_f="21725" txt_i="13941" txt_f="14079">Strategies to increase self-esteem and regulate emotions. Pain experience and recurrent invalidation. Social support (family and friends).</offsets></td></tr><tr><td align="left"><bold><offsets xml_i="21762" xml_f="21773" txt_i="14080" txt_f="14091">Session 6: </offsets></bold><offsets xml_i="21780" xml_f="21803" txt_i="14091" txt_f="14114">Relaxation training-III</offsets></td></tr><tr><td align="left"><bold><offsets xml_i="21840" xml_f="21851" txt_i="14115" txt_f="14126">Session 7: </offsets></bold><offsets xml_i="21858" xml_f="21875" txt_i="14126" txt_f="14143">Holistic medicine</offsets></td></tr><tr><td align="left"><bold><offsets xml_i="21912" xml_f="21923" txt_i="14144" txt_f="14155">Session 8: </offsets></bold><offsets xml_i="21930" xml_f="21952" txt_i="14155" txt_f="14177">Relaxation training-IV</offsets></td></tr><tr><td align="left"><bold><offsets xml_i="21989" xml_f="22000" txt_i="14178" txt_f="14189">Session 9: </offsets></bold><offsets xml_i="22007" xml_f="22185" txt_i="14189" txt_f="14367">Benefits of physical exercise in FM. Qualitative assessment of the intervention program. Resolving doubts. Discussion concerning the strengths and weaknesses of the intervention.</offsets></td></tr></tbody></table></table-wrap><p><offsets xml_i="22227" xml_f="22660" txt_i="14368" txt_f="14801">In order to avoid conversations concerning the psycho-educational program among patients from different groups, we will remind the participants from the intervention of the condition that they are not allowed to talk about the program with those persons that are not attending their group. Before baseline assessment, an explanatory note addressing this important issue will be delivered to the patients participating in the program.</offsets></p></sec><sec><title><offsets xml_i="22682" xml_f="22706" txt_i="14803" txt_f="14827">Forecast execution dates</offsets></title><p><offsets xml_i="22717" xml_f="22764" txt_i="14828" txt_f="14875">Initial recruitment of patients: September 2007</offsets></p><p><offsets xml_i="22771" xml_f="22822" txt_i="14876" txt_f="14927">Deadline for recruitment of patients: November 2008</offsets></p><p><offsets xml_i="22829" xml_f="22885" txt_i="14928" txt_f="14984">Deadline for period of patient monitoring: December 2009</offsets></p><p><offsets xml_i="22892" xml_f="22920" txt_i="14985" txt_f="15013">Publication of results: 2010</offsets></p></sec><sec><title><offsets xml_i="22942" xml_f="22962" txt_i="15015" txt_f="15035">Statistical analyses</offsets></title><p><offsets xml_i="22973" xml_f="23144" txt_i="15036" txt_f="15207">Data collected will be analysed using SAS statistical analysis software (SAS Institute Inc. 1999. v8.0, 4th ed) and employing both quantitative and qualitative techniques.</offsets></p><p><offsets xml_i="23151" xml_f="23616" txt_i="15208" txt_f="15673">First, the intervention and control groups will be compared in order to verify that there are no significant differences between them in socio-demographic terms, clinical baseline data, etc. We shall use mean and standard deviation (SD) in continuous variables and percentages in categorical variables. For comparisons we shall use the Student-T test for continuous variables and the Chi-square test for categorical variables. Non-parametric tests may also be used.</offsets></p><p><offsets xml_i="23623" xml_f="24646" txt_i="15674" txt_f="16697">Given that we have one between-groups factor with two levels (2 Groups: Intervention and Control) and one within-subjects factor with five levels (Baseline and 4 follow-up assessments: 0, 1, 2, 6, and 12), a 2 × 5 mixed factorial ANOVA will be performed to study the effect of the psycho-educational program on the quality of life. Then, between-subjects planned comparisons may also be used (post-hoc comparisons with independent samples T-test). If we observe differences between groups in quality of life prior to treatment, one-way analyses of covariance will be carried out using baseline scores as a covariate). In addition, we shall carry out a logistic regression analysis taking the groups as dependent variable (the target variable is a categorical variable with two categories: Intervention and Control) and the collected measures as independent variables. This analysis will let us to know the association between the intervention and the cost of the healthcare resources, controlling for the rest of variables.</offsets></p></sec><sec><title><offsets xml_i="24668" xml_f="24689" txt_i="16699" txt_f="16720">Cost-utility analyses</offsets></title><p><offsets xml_i="24700" xml_f="24769" txt_i="16721" txt_f="16790">Societal cost perspective will be used for the calculation of costs. </offsets><italic><offsets xml_i="24777" xml_f="24790" txt_i="16790" txt_f="16803">Direct costs </offsets></italic><offsets xml_i="24799" xml_f="25519" txt_i="16803" txt_f="17523">are going to be calculated by adding the costs derived from any medication and use of health-related services (general practitioner sessions, specialized medical sessions, emergency room sessions, and hospital in-patient stay). The cost of medications will be calculated by determining the price per milligram during the study, according to the International Vademecum (Red Book) 2007–2009, including value-added tax. Total costs of pharmacological treatment will be calculated by multiplying the price per milligram by the daily dose in milligrams and the number of days receiving such treatment. Costs derived from the use of health-related services will be calculated considering the SOIKOS unit costs database (25). </offsets><italic><offsets xml_i="25527" xml_f="25542" txt_i="17523" txt_f="17538">Indirect costs </offsets></italic><offsets xml_i="25551" xml_f="25688" txt_i="17538" txt_f="17675">will be calculated considering the days under sick leave and multiplying them by the minimum daily wage in Spain for 2007–2009. Finally, </offsets><italic><offsets xml_i="25696" xml_f="25708" txt_i="17675" txt_f="17687">total costs </offsets></italic><offsets xml_i="25717" xml_f="25780" txt_i="17687" txt_f="17750">are going to be calculated by adding direct and indirect costs.</offsets></p><p><offsets xml_i="25787" xml_f="26293" txt_i="17751" txt_f="18257">In Spain, the National Healthcare Service (NHS) is financed by the general taxes levied by the state. In the municipalities where the study is carried out, it is administered by the autonomous government of Catalonia. Medical visits and hospital admissions are fully covered by the NHS. Medications prescribed are fully covered for retired persons, and partially for those still employed. Sick leave requires a physician's authorization, and patients unable to work continue receiving most of their salary.</offsets></p><p><offsets xml_i="26300" xml_f="26495" txt_i="18258" txt_f="18453">When performing cost-utility analyses, two or more therapeutical options are compared in order to determine which one is the best for maximizing the benefits in light of the available resources [</offsets><xref ref-type="bibr" rid="B25"><offsets xml_i="26527" xml_f="26529" txt_i="18453" txt_f="18455">25</offsets></xref><offsets xml_i="26536" xml_f="26537" txt_i="18455" txt_f="18456">,</offsets><xref ref-type="bibr" rid="B26"><offsets xml_i="26569" xml_f="26571" txt_i="18456" txt_f="18458">26</offsets></xref><offsets xml_i="26578" xml_f="26930" txt_i="18458" txt_f="18810">]. This is achieved by calculating the relationship between the costs of a given intervention (e.g. A) and its consequences, expressed in QALYs, compared with another (e.g. B). This relative value is called incremental cost-utility ratio (ICUR), and it expresses the relationship between the costs and effects of one intervention compared with another.</offsets></p><p><offsets xml_i="26937" xml_f="27040" txt_i="18811" txt_f="18914">As the duration of the study is only 12 months, neither costs nor outcomes are subject to discounting [</offsets><xref ref-type="bibr" rid="B26"><offsets xml_i="27072" xml_f="27074" txt_i="18914" txt_f="18916">26</offsets></xref><offsets xml_i="27081" xml_f="27347" txt_i="18916" txt_f="19182">]. Treatment costs during 12 months follow-up will be modelled by a multivariate gamma regression with a log link. Gamma modelling has been suggested as a suitable choice for analysing cost data, taking into account the skewing of the distribution of the cost data [</offsets><xref ref-type="bibr" rid="B27"><offsets xml_i="27379" xml_f="27381" txt_i="19182" txt_f="19184">27</offsets></xref><offsets xml_i="27388" xml_f="27389" txt_i="19184" txt_f="19185">,</offsets><xref ref-type="bibr" rid="B28"><offsets xml_i="27421" xml_f="27423" txt_i="19185" txt_f="19187">28</offsets></xref><offsets xml_i="27430" xml_f="27581" txt_i="19187" txt_f="19338">]. QALYs gained in the first and last six months after the beginning of the program will be approximated by measuring the area under the curve (Figure </offsets><xref ref-type="fig" rid="F1"><offsets xml_i="27611" xml_f="27612" txt_i="19338" txt_f="19339">1</offsets></xref><offsets xml_i="27619" xml_f="27621" txt_i="19339" txt_f="19341">).</offsets></p><fig position="float" id="F1"><label><offsets xml_i="27662" xml_f="27670" txt_i="19342" txt_f="19350">Figure 1</offsets></label><caption><p><offsets xml_i="27690" xml_f="27800" txt_i="19350" txt_f="19460">Formulas for calculating the QALYs gained in the first and last six months after the beginning of the program.</offsets></p></caption><graphic xlink:href="1471-2474-9-2-1"></graphic></fig><p><offsets xml_i="27871" xml_f="27885" txt_i="19461" txt_f="19475">In the Figure </offsets><xref ref-type="fig" rid="F1"><offsets xml_i="27915" xml_f="27916" txt_i="19475" txt_f="19476">1</offsets></xref><offsets xml_i="27923" xml_f="27926" txt_i="19476" txt_f="19479">, d</offsets><sub><offsets xml_i="27931" xml_f="27935" txt_i="19479" txt_f="19483">0–6 </offsets></sub><offsets xml_i="27941" xml_f="28038" txt_i="19483" txt_f="19580">is the incremental treatment effect on change in EQ-5D utility score for the first 6 months and d</offsets><sub><offsets xml_i="28043" xml_f="28047" txt_i="19580" txt_f="19584">6–12</offsets></sub><offsets xml_i="28053" xml_f="28665" txt_i="19584" txt_f="20196">the incremental treatment effect on change in EQ-5D utility score for the last 6 months. These incremental treatment effects will be estimated using multivariate ordinary least squares regressions, adjusting for baseline differences among treatment groups. The covariates included in the models will be: age, gender, years of education, employment and marital status, baseline FIQ and EQ-5D utility scores, and type of medication prescribed. To address uncertainty in the ICUR sampling distribution, non-parametric bootstrapping with five thousand replications will be carried out for each treatment comparison [</offsets><xref ref-type="bibr" rid="B29"><offsets xml_i="28697" xml_f="28699" txt_i="20196" txt_f="20198">29</offsets></xref><offsets xml_i="28706" xml_f="28708" txt_i="20198" txt_f="20200">].</offsets></p></sec></sec><sec><title><offsets xml_i="28736" xml_f="28746" txt_i="20203" txt_f="20213">Discussion</offsets></title><p><offsets xml_i="28757" xml_f="28831" txt_i="20214" txt_f="20288">FM is a chronic illness that seriously alters the well-being of patients [</offsets><xref ref-type="bibr" rid="B1"><offsets xml_i="28862" xml_f="28863" txt_i="20288" txt_f="20289">1</offsets></xref><offsets xml_i="28870" xml_f="28871" txt_i="20289" txt_f="20290">-</offsets><xref ref-type="bibr" rid="B3"><offsets xml_i="28902" xml_f="28903" txt_i="20290" txt_f="20291">3</offsets></xref><offsets xml_i="28910" xml_f="28911" txt_i="20291" txt_f="20292">,</offsets><xref ref-type="bibr" rid="B30"><offsets xml_i="28943" xml_f="28945" txt_i="20292" txt_f="20294">30</offsets></xref><offsets xml_i="28952" xml_f="29252" txt_i="20294" txt_f="20594">]. One of the main expected contributions of the present project is that we will have the opportunity to assess not only whether a multimodal psycho-educational program is feasible in primary health care, but also whether it is more cost-effective than the usual care provided for FM in this context.</offsets></p><p><offsets xml_i="29259" xml_f="29574" txt_i="20595" txt_f="20910">Although FM has an irregular course that causes oscillations in the patients' quality of life, the random assignment of the participants to the conditions will minimize the differences not produced by the intervention. Baseline comparisons between groups will permit detection of possible pre-treatment differences.</offsets></p><p><offsets xml_i="29581" xml_f="29805" txt_i="20911" txt_f="21135">In our opinion, the application of the program in PC entails a low outlay because nursing personnel may be trained to develop the program, as in other recent educational programs developed for a number of chronic illnesses [</offsets><xref ref-type="bibr" rid="B31"><offsets xml_i="29837" xml_f="29839" txt_i="21135" txt_f="21137">31</offsets></xref><offsets xml_i="29846" xml_f="29847" txt_i="21137" txt_f="21138">,</offsets><xref ref-type="bibr" rid="B32"><offsets xml_i="29879" xml_f="29881" txt_i="21138" txt_f="21140">32</offsets></xref><offsets xml_i="29888" xml_f="29890" txt_i="21140" txt_f="21142">].</offsets></p></sec><sec><title><offsets xml_i="29912" xml_f="29931" txt_i="21144" txt_f="21163">Competing interests</offsets></title><p><offsets xml_i="29942" xml_f="30002" txt_i="21164" txt_f="21224">The author(s) declare that they have no competing interests.</offsets></p></sec><sec><title><offsets xml_i="30024" xml_f="30046" txt_i="21226" txt_f="21248">Authors' contributions</offsets></title><p><offsets xml_i="30057" xml_f="30454" txt_i="21249" txt_f="21646">RF is the principal investigator and developed the original idea for the research. The study design was made by RF, MTP, ASB, EB, MJ, CV and JMR. These authors, with the help of JVL and AM, designed and planned the intervention that is going to be evaluated. ASB and JVL developed the statistical methods. All authors have corrected draft versions and approved the final version of the manuscript.</offsets></p></sec><sec><title><offsets xml_i="30476" xml_f="30499" txt_i="21648" txt_f="21671">Pre-publication history</offsets></title><p><offsets xml_i="30510" xml_f="30574" txt_i="21672" txt_f="21736">The pre-publication history for this paper can be accessed here:</offsets></p><p><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2474/9/2/prepub"></ext-link></p></sec></body><back><ack><sec><title>Acknowledgements</title><p></p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Collado</surname><given-names>A</given-names></name><name><surname>Alijotas</surname><given-names>J</given-names></name><name><surname>Benito</surname><given-names>P</given-names></name><name><surname>Alegre</surname><given-names>C</given-names></name><name><surname>Romera</surname><given-names>M</given-names></name><name><surname>Sanudo</surname><given-names>I</given-names></name><name><surname>Martin</surname><given-names>R</given-names></name><name><surname>Peri</surname><given-names>JM</given-names></name><name><surname>Cots</surname><given-names>JM</given-names></name></person-group><article-title>Consensus report on the diagnosis and treatment of fibromyalgia in Catalonia</article-title><source>Med Clin (Barc)</source><year>2002</year><volume>118</volume><fpage>745</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">12049708</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Leza</surname><given-names>JC</given-names></name></person-group><article-title>Fibromyalgia: a challenge for neuroscience</article-title><source>Rev Neurol</source><year>2003</year><volume>36</volume><fpage>1165</fpage><lpage>75</lpage><pub-id pub-id-type="pmid">12833238</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carmona</surname><given-names>L</given-names></name><name><surname>Villaverde</surname><given-names>V</given-names></name><name><surname>Hernández-García</surname><given-names>C</given-names></name><name><surname>Ballina</surname><given-names>J</given-names></name><name><surname>Gabriel</surname><given-names>R</given-names></name><name><surname>Laffon</surname><given-names>A</given-names></name><collab>EPISER Study Group</collab></person-group><article-title>The prevalence of rheumatoid arthritis in the general population of Spain</article-title><source>Rheumatology (Oxford)</source><year>2002</year><volume>41</volume><fpage>88</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">11792885</pub-id><pub-id pub-id-type="doi">10.1093/rheumatology/41.1.88</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wolfe</surname><given-names>F</given-names></name><name><surname>Smythe</surname><given-names>HA</given-names></name><name><surname>Yunus</surname><given-names>MB</given-names></name><name><surname>Bennett</surname><given-names>RM</given-names></name><name><surname>Bombardier</surname><given-names>C</given-names></name><name><surname>Goldenberg</surname><given-names>DL</given-names></name><name><surname>Tugwell</surname><given-names>P</given-names></name><name><surname>Campbell</surname><given-names>SM</given-names></name><name><surname>Abeles</surname><given-names>M</given-names></name><name><surname>Clark</surname><given-names>P</given-names></name></person-group><article-title>The American College of Rheumatology 1990 criteria for the classification of fibromyalgia</article-title><source>Arthritis Rheum</source><year>1990</year><volume>33</volume><fpage>160</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">2306288</pub-id><pub-id pub-id-type="doi">10.1002/art.1780330203</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bosch</surname><given-names>E</given-names></name><name><surname>Sáenz</surname><given-names>N</given-names></name><name><surname>Valls</surname><given-names>M</given-names></name><name><surname>Viñolas</surname><given-names>S</given-names></name></person-group><article-title>Study of quality of life of patients with fibromyalgia: impact of a health education programme</article-title><source>Aten Primaria</source><year>2002</year><volume>30</volume><fpage>16</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">12106575</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sedó</surname><given-names>R</given-names></name><name><surname>Ancochea</surname><given-names>J</given-names></name></person-group><article-title>A reflection on fibromyalgia</article-title><source>Aten Primaria</source><year>2002</year><volume>29</volume><fpage>562</fpage><lpage>564</lpage><pub-id pub-id-type="pmid">12061988</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brecher</surname><given-names>LS</given-names></name><name><surname>Cymet</surname><given-names>TC</given-names></name></person-group><article-title>A practical approach to fibromyalgia</article-title><source>J Am Osteopath Assoc</source><year>2001</year><volume>101</volume><fpage>S12</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">11392205</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Desmeules</surname><given-names>JA</given-names></name><name><surname>Cedraschi</surname><given-names>C</given-names></name><name><surname>Rapiti</surname><given-names>E</given-names></name><name><surname>Baumgartner</surname><given-names>E</given-names></name><name><surname>Finckh</surname><given-names>A</given-names></name><name><surname>Cohen</surname><given-names>P</given-names></name><name><surname>Dayer</surname><given-names>P</given-names></name><name><surname>Vischer</surname><given-names>TL</given-names></name></person-group><article-title>Neurophysiologic evidence for a central sensitization in patients with fibromyalgia</article-title><source>Arthritis Rheum</source><year>2003</year><volume>48</volume><fpage>1420</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">12746916</pub-id><pub-id pub-id-type="doi">10.1002/art.10893</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nampiaparampil</surname><given-names>DE</given-names></name><name><surname>Shmerling</surname><given-names>RH</given-names></name></person-group><article-title>A review of fibromyalgia</article-title><source>Am J Manag Care</source><year>2004</year><volume>10</volume><fpage>794</fpage><lpage>800</lpage><pub-id pub-id-type="pmid">15623268</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lemstra</surname><given-names>M</given-names></name><name><surname>Olszynski</surname><given-names>WP</given-names></name></person-group><article-title>The effectiveness of multidisciplinary rehabilitation in the treatment of fibromyalgia: a randomized controlled trial</article-title><source>Clin J Pain</source><year>2005</year><volume>21</volume><fpage>166</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">15722810</pub-id><pub-id pub-id-type="doi">10.1097/00002508-200503000-00008</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sprott</surname><given-names>H</given-names></name></person-group><article-title>What can rehabilitation interventions achieve in patients with primary fibromyalgia?</article-title><source>Curr Opin Rheumatol</source><year>2003</year><volume>15</volume><fpage>145</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">12598803</pub-id><pub-id pub-id-type="doi">10.1097/00002281-200303000-00011</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Andollo</surname><given-names>I</given-names></name><name><surname>Sánchez</surname><given-names>A</given-names></name><name><surname>Grandes</surname><given-names>G</given-names></name></person-group><article-title>Inadequate analysis casts doubt on the benefits of health education in fibromyalgia [Abstract]</article-title><source>Aten Primaria</source><year>2003</year><volume>31</volume><fpage>204</fpage><pub-id pub-id-type="pmid">12622993</pub-id><pub-id pub-id-type="doi">10.1157/13044280</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Denison</surname><given-names>B</given-names></name></person-group><article-title>Touch the pain away: new research on therapeutic touch and persons with fibromyalgia syndrome</article-title><source>Holist Nurs Pract</source><year>2004</year><volume>18</volume><fpage>142</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">15222602</pub-id></citation></ref><ref id="B14"><citation citation-type="other"><person-group person-group-type="author"><collab>Direcció General de Planificació i Avaluació Sanitaria. Departament de Salut. Generalitat de Catalunya</collab></person-group><source>Nou model d'atenció a la fibromiàlgia i la síndrome de fatiga crònica Barcelona</source><year>2006</year></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schachter</surname><given-names>CL</given-names></name><name><surname>Busch</surname><given-names>AJ</given-names></name><name><surname>Peloso</surname><given-names>PM</given-names></name><name><surname>Sheppard</surname><given-names>MS</given-names></name></person-group><article-title>Effects of short versus long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial</article-title><source>Phys Ther</source><year>2003</year><volume>83</volume><fpage>340</fpage><lpage>58</lpage><pub-id pub-id-type="pmid">12665405</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gowans</surname><given-names>SE</given-names></name><name><surname>Dehueck</surname><given-names>A</given-names></name><name><surname>Voss</surname><given-names>S</given-names></name><name><surname>Silaj</surname><given-names>A</given-names></name><name><surname>Abbey</surname><given-names>SE</given-names></name></person-group><article-title>Six-month and one-year follow-up of 23 weeks of aerobic exercise for individuals with fibromyalgia</article-title><source>Arthritis Rheum</source><year>2004</year><volume>51</volume><fpage>890</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">15593364</pub-id><pub-id pub-id-type="doi">10.1002/art.20828</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Taggart</surname><given-names>HM</given-names></name><name><surname>Arslanian</surname><given-names>CL</given-names></name><name><surname>Bae</surname><given-names>S</given-names></name><name><surname>Singh</surname><given-names>K</given-names></name></person-group><article-title>Effects of T'ai Chi exercise on fibromyalgia symptoms and health-related quality of life</article-title><source>Orthop Nurs</source><year>2003</year><volume>22</volume><fpage>353</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">14595996</pub-id><pub-id pub-id-type="doi">10.1097/00006416-200309000-00013</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cedraschi</surname><given-names>C</given-names></name><name><surname>Desmeules</surname><given-names>J</given-names></name><name><surname>Rapiti</surname><given-names>E</given-names></name><name><surname>Baumgartner</surname><given-names>E</given-names></name><name><surname>Cohen</surname><given-names>P</given-names></name><name><surname>Finckh</surname><given-names>A</given-names></name><name><surname>Allaz</surname><given-names>AF</given-names></name><name><surname>Vischer</surname><given-names>TL</given-names></name></person-group><article-title>Fibromyalgia: a randomised, controlled trial of a treatment programme based on self management</article-title><source>Ann Rheum Dis</source><year>2004</year><volume>63</volume><fpage>290</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">14962965</pub-id><pub-id pub-id-type="doi">10.1136/ard.2002.004945</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>King</surname><given-names>SJ</given-names></name><name><surname>Wessel</surname><given-names>J</given-names></name><name><surname>Bhambhani</surname><given-names>Y</given-names></name><name><surname>Sholter</surname><given-names>D</given-names></name><name><surname>Maksymowych</surname><given-names>W</given-names></name></person-group><article-title>The effects of exercise and education, individually or combined, in women with fibromyalgia</article-title><source>J Rheumatol</source><year>2002</year><volume>29</volume><fpage>2620</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">12465163</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mannerkorpi</surname><given-names>K</given-names></name><name><surname>Ahlmen</surname><given-names>M</given-names></name><name><surname>Ekdahl</surname><given-names>C</given-names></name></person-group><article-title>Six- and 24-month follow-up of pool exercise therapy and education for patients with fibromyalgia</article-title><source>Scand J Rheumatol</source><year>2002</year><volume>31</volume><fpage>306</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">12455823</pub-id><pub-id pub-id-type="doi">10.1080/030097402760375223</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martínez</surname><given-names>JE</given-names></name><name><surname>Ferraz</surname><given-names>MB</given-names></name><name><surname>Inoe</surname><given-names>E</given-names></name><name><surname>Atra</surname><given-names>E</given-names></name></person-group><article-title>Fibromyalgia versus rheumatoid arthritis: a longitudinal comparison of the quality of life</article-title><source>J Rheumatol</source><year>1995</year><volume>22</volume><fpage>270</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">7738950</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Badia</surname><given-names>X</given-names></name><name><surname>Roset</surname><given-names>M</given-names></name><name><surname>Montserrat</surname><given-names>S</given-names></name><name><surname>Herdman</surname><given-names>M</given-names></name><name><surname>Segura</surname><given-names>A</given-names></name></person-group><article-title>The Spanish version of EuroQol: a description and its applications. European Quality of Life scale</article-title><source>Med Clin (Barc)</source><year>1999</year><volume>112</volume><fpage>79</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">10618804</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rivera</surname><given-names>J</given-names></name><name><surname>González</surname><given-names>T</given-names></name></person-group><article-title>The Fibromyalgia Impact Questionnaire: A validated Spanish version to assess the health status in women with fibromyalgia</article-title><source>Clin and Exp Rheumatol</source><year>2004</year><volume>22</volume><fpage>554</fpage><lpage>60</lpage></citation></ref><ref id="B24"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Knapp</surname><given-names>M</given-names></name><collab>(PSSRU and Centre for Economics of Mental Health, Institute of Psychiatry, University of Kent)</collab></person-group><source>Economic Evaluation of Mental Health Care</source><year>1995</year><publisher-name>Ashgate Publishing Group</publisher-name></citation></ref><ref id="B25"><citation citation-type="other"><person-group person-group-type="author"><collab>Centro de Estudios de Economía de la Salud y Política Social</collab></person-group><source>Base de Datos de Costes Soikos sanitarias Barcelona</source><year>2001</year></citation></ref><ref id="B26"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Drummond</surname><given-names>MF</given-names></name><name><surname>Sculpher</surname><given-names>MJ</given-names></name><name><surname>Torrance</surname><given-names>GW</given-names></name><name><surname>O'Brien</surname><given-names>BJ</given-names></name><name><surname>Stoddart</surname><given-names>GL</given-names></name></person-group><source>Methods for the Economic Evaluation of Health Care Programmes</source><year>2005</year><edition>Third</edition><publisher-name>New York: Oxford University Press</publisher-name></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dodd</surname><given-names>S</given-names></name><name><surname>Bassi</surname><given-names>A</given-names></name><name><surname>Bodger</surname><given-names>K</given-names></name><name><surname>Williamson</surname><given-names>P</given-names></name></person-group><article-title>A comparison of multivariable regression models to analyse cost data</article-title><source>J Eval Clin Pract</source><year>2006</year><volume>12</volume><fpage>76</fpage><lpage>86</lpage><pub-id pub-id-type="pmid">16422782</pub-id><pub-id pub-id-type="doi">10.1111/j.1365-2753.2006.00610.x</pub-id></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Austin</surname><given-names>PC</given-names></name><name><surname>Ghali</surname><given-names>WA</given-names></name><name><surname>Tu</surname><given-names>JV</given-names></name></person-group><article-title>A comparison of several regression models for analysing cost of CABG surgery</article-title><source>Stat Med</source><year>2003</year><volume>22</volume><fpage>2799</fpage><lpage>815</lpage><pub-id pub-id-type="pmid">12939787</pub-id><pub-id pub-id-type="doi">10.1002/sim.1442</pub-id></citation></ref><ref id="B29"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Efron</surname><given-names>B</given-names></name><name><surname>Tibshirani</surname><given-names>RJ</given-names></name></person-group><source>An introduction to the bootstrap</source><year>1998</year><edition>2</edition><publisher-name>Boca Ratón, FL: Chapman and Hall/CRC</publisher-name></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ejlertsson</surname><given-names>G</given-names></name><name><surname>Edén</surname><given-names>L</given-names></name><name><surname>Leden</surname><given-names>I</given-names></name></person-group><article-title>Predictors of positive health in disability pensioners: a population-based questionnaire study using Positive Odds Ratio</article-title><source>BMC Public Health</source><year>2002</year><volume>2</volume><fpage>20</fpage><pub-id pub-id-type="pmid">12225618</pub-id><pub-id pub-id-type="doi">10.1186/1471-2458-2-20</pub-id></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Laatikainen</surname><given-names>T</given-names></name><name><surname>Dunbar</surname><given-names>JA</given-names></name><name><surname>Chapman</surname><given-names>A</given-names></name><name><surname>Kilkkinen</surname><given-names>A</given-names></name><name><surname>Vartiainen</surname><given-names>E</given-names></name><name><surname>Heistaro</surname><given-names>S</given-names></name><name><surname>Philpot</surname><given-names>B</given-names></name><name><surname>Absetz</surname><given-names>P</given-names></name><name><surname>Bunker</surname><given-names>S</given-names></name><name><surname>O'Neil</surname><given-names>A</given-names></name><name><surname>Reddy</surname><given-names>P</given-names></name><name><surname>Best</surname><given-names>JD</given-names></name><name><surname>Janus</surname><given-names>ED</given-names></name></person-group><article-title>Prevention of Type 2 Diabetes by lifestyle intervention in an Australian primary health care setting: Greater Green Triangle (GGT) Diabetes Prevention Project</article-title><source>BMC Public Health</source><year>2007</year><volume>7</volume><fpage>249</fpage><pub-id pub-id-type="pmid">17877832</pub-id><pub-id pub-id-type="doi">10.1186/1471-2458-7-249</pub-id></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Drevenhorn</surname><given-names>E</given-names></name><name><surname>Kjellgren</surname><given-names>KI</given-names></name><name><surname>Bengtson</surname><given-names>A</given-names></name></person-group><article-title>Outcomes following a programme for lifestyle changes with people with hypertension</article-title><source>J Clin Nurs</source><year>2007</year><volume>16</volume><fpage>144</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">17584423</pub-id><pub-id pub-id-type="doi">10.1111/j.1365-2702.2005.01493.x</pub-id></citation></ref></ref-list></back></article>